Correlation Between Landos Biopharma and Apollomics
Can any of the company-specific risk be diversified away by investing in both Landos Biopharma and Apollomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Landos Biopharma and Apollomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Landos Biopharma and Apollomics Class A, you can compare the effects of market volatilities on Landos Biopharma and Apollomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Landos Biopharma with a short position of Apollomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Landos Biopharma and Apollomics.
Diversification Opportunities for Landos Biopharma and Apollomics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Landos and Apollomics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Landos Biopharma and Apollomics Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollomics Class A and Landos Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Landos Biopharma are associated (or correlated) with Apollomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollomics Class A has no effect on the direction of Landos Biopharma i.e., Landos Biopharma and Apollomics go up and down completely randomly.
Pair Corralation between Landos Biopharma and Apollomics
If you would invest 1,320 in Apollomics Class A on September 12, 2024 and sell it today you would lose (550.00) from holding Apollomics Class A or give up 41.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Landos Biopharma vs. Apollomics Class A
Performance |
Timeline |
Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apollomics Class A |
Landos Biopharma and Apollomics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Landos Biopharma and Apollomics
The main advantage of trading using opposite Landos Biopharma and Apollomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Landos Biopharma position performs unexpectedly, Apollomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will offset losses from the drop in Apollomics' long position.Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
Apollomics vs. Yuexiu Transport Infrastructure | Apollomics vs. Spyre Therapeutics | Apollomics vs. Agnico Eagle Mines | Apollomics vs. Century Aluminum |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stocks Directory Find actively traded stocks across global markets |